900000000000509007: United States of America English language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\US English

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
US English	Is a	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
3-3'dichlorobenzidine (substance)	Preferred (foundation metadata concept)
3-4 hourly	Acceptable (foundation metadata concept)
3-4 times a week	Acceptable (foundation metadata concept)
3-4x /day	Acceptable (foundation metadata concept)
3-4x /wk	Acceptable (foundation metadata concept)
3-Aminoisobutyrate measurement	Preferred (foundation metadata concept)
3-Aminoisobutyrate measurement (procedure)	Preferred (foundation metadata concept)
3-Beta-hydroxy-delta-5-C27-steroid dehydrogenase deficiency	Preferred (foundation metadata concept)
3-Beta-hydroxy-delta-5-C27-steroid dehydrogenase deficiency (disorder)	Preferred (foundation metadata concept)
3-Dimensional	Acceptable (foundation metadata concept)
3-He	Acceptable (foundation metadata concept)
3-Hydroxy isovaleric acid	Preferred (foundation metadata concept)
3-Hydroxy isovaleric acid (substance)	Preferred (foundation metadata concept)
3-Hydroxy,3-methylglutarate measurement	Preferred (foundation metadata concept)
3-Hydroxy,3-methylglutarate measurement (procedure)	Preferred (foundation metadata concept)
3-Hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitor adverse reaction	Acceptable (foundation metadata concept)
3-Hydroxy-3-methylglutaryl coenzyme A lyase	Preferred (foundation metadata concept)
3-Hydroxy-3-methylglutaryl coenzyme A lyase (substance)	Preferred (foundation metadata concept)
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor adverse reaction	Acceptable (foundation metadata concept)
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor adverse reaction (disorder)	Preferred (foundation metadata concept)
3-Hydroxy-3-methylglutaryl-CoA lyase	Acceptable (foundation metadata concept)
3-Hydroxy-3-methylglutaryl-CoA lyase deficiency	Acceptable (foundation metadata concept)
3-Hydroxy-3-methylglutaryl-CoA lyase deficiency	Acceptable (foundation metadata concept)
3-Hydroxy-3-methylglutaryl-coenzyme A (HMG CoA) reductase inhibitor allergy	Acceptable (foundation metadata concept)
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor allergy	Acceptable (foundation metadata concept)
3-Hydroxyadipate measurement	Preferred (foundation metadata concept)
3-Hydroxyadipate measurement (procedure)	Preferred (foundation metadata concept)
3-Hydroxybutanoate	Acceptable (foundation metadata concept)
3-Hydroxybutylcarnitine	Preferred (foundation metadata concept)
3-Hydroxybutylcarnitine (substance)	Preferred (foundation metadata concept)
3-Hydroxybutylcarnitine measurement	Preferred (foundation metadata concept)
3-Hydroxybutylcarnitine measurement (procedure)	Preferred (foundation metadata concept)
3-Hydroxybutyrate + acetoacetate	Preferred (foundation metadata concept)
3-Hydroxybutyrate + acetoacetate (substance)	Preferred (foundation metadata concept)
3-Hydroxybutyrate + gamma aminobutyric acid	Preferred (foundation metadata concept)
3-Hydroxybutyrate + gamma aminobutyric acid (substance)	Preferred (foundation metadata concept)
3-Hydroxybutyrate dehydrogenase	Preferred (foundation metadata concept)
3-Hydroxybutyrate dehydrogenase (substance)	Preferred (foundation metadata concept)
3-Hydroxybutyrate measurement	Preferred (foundation metadata concept)
3-Hydroxybutyrate measurement (procedure)	Preferred (foundation metadata concept)
3-Hydroxybutyrylcarnitine + malonylcarnitine	Preferred (foundation metadata concept)
3-Hydroxybutyrylcarnitine + malonylcarnitine (substance)	Preferred (foundation metadata concept)
3-Hydroxydodecanedioate measurement	Preferred (foundation metadata concept)
3-Hydroxydodecanedioate measurement (procedure)	Preferred (foundation metadata concept)
3-Hydroxyglutarate measurement	Preferred (foundation metadata concept)
3-Hydroxyglutarate measurement (procedure)	Preferred (foundation metadata concept)
3-Hydroxyhexanoylcarnitine + glutarylcarnitine	Preferred (foundation metadata concept)
3-Hydroxyhexanoylcarnitine + glutarylcarnitine (substance)	Preferred (foundation metadata concept)
3-Hydroxyisobutyrate measurement	Preferred (foundation metadata concept)
3-Hydroxyisobutyrate measurement (procedure)	Preferred (foundation metadata concept)
3-Hydroxyisobutyric aciduria	Preferred (foundation metadata concept)
3-Hydroxyisobutyric aciduria (disorder)	Preferred (foundation metadata concept)
3-Hydroxyisovalerylcarnitine + 2-methyl,3-hydroxybutyrylcarnitine	Preferred (foundation metadata concept)
3-Hydroxyisovalerylcarnitine + 2-methyl,3-hydroxybutyrylcarnitine (substance)	Preferred (foundation metadata concept)
3-Hydroxyisovalerylcarnitine + methylmalonylcarnitine	Preferred (foundation metadata concept)
3-Hydroxyisovalerylcarnitine + methylmalonylcarnitine (substance)	Preferred (foundation metadata concept)
3-Hydroxyisovalerylcarnitine measurement	Preferred (foundation metadata concept)
3-Hydroxyisovalerylcarnitine measurement (procedure)	Preferred (foundation metadata concept)
3-Hydroxylinoleoylcarnitine measurement	Preferred (foundation metadata concept)
3-Hydroxylinoleoylcarnitine measurement (procedure)	Preferred (foundation metadata concept)
3-Hydroxyoctanoylcarnitine + malonylcarnitine	Preferred (foundation metadata concept)
3-Hydroxyoctanoylcarnitine + malonylcarnitine (substance)	Preferred (foundation metadata concept)
3-Hydroxyoleoylcarnitine measurement	Preferred (foundation metadata concept)
3-Hydroxyoleoylcarnitine measurement (procedure)	Preferred (foundation metadata concept)
3-Hydroxypalmitoylcarnitine measurement	Preferred (foundation metadata concept)
3-Hydroxypalmitoylcarnitine measurement (procedure)	Preferred (foundation metadata concept)
3-Hydroxypropionate measurement	Preferred (foundation metadata concept)
3-Hydroxypropionate measurement (procedure)	Preferred (foundation metadata concept)
3-Hydroxysebacate measurement	Preferred (foundation metadata concept)
3-Hydroxysebacate measurement (procedure)	Preferred (foundation metadata concept)
3-Hydroxytetradecadienoylcarnitine measurement	Preferred (foundation metadata concept)
3-Hydroxytetradecadienoylcarnitine measurement (procedure)	Preferred (foundation metadata concept)
3-Hydroxytetradecenoylcarnitine measurement	Preferred (foundation metadata concept)
3-Hydroxytetradecenoylcarnitine measurement (procedure)	Preferred (foundation metadata concept)
3-Hydroxyvalerate measurement	Preferred (foundation metadata concept)
3-Hydroxyvalerate measurement (procedure)	Preferred (foundation metadata concept)
3-Ketoacid CoA transferase deficiency	Acceptable (foundation metadata concept)
3-Ketoacyl-CoA thiolase deficiency	Acceptable (foundation metadata concept)
3-Ketoacyl-CoA triolase deficiency	Preferred (foundation metadata concept)
3-Ketoacyl-coenzyme A triolase deficiency	Acceptable (foundation metadata concept)
3-Ketoacyl-coenzyme A triolase deficiency (disorder)	Preferred (foundation metadata concept)
3-Ketothiolase deficiency	Acceptable (foundation metadata concept)
3-Ketothiolase deficiency	Acceptable (foundation metadata concept)
3-M syndrome	Preferred (foundation metadata concept)
3-Methoxy-4,5- methylenedioxyamphetamine	Preferred (foundation metadata concept)
3-Methoxy-4,5- methylenedioxyamphetamine (substance)	Preferred (foundation metadata concept)
3-Methoxy-4-hydroxphenylglycol (MHPG) measurement, urine	Acceptable (foundation metadata concept)
3-Methoxy-4-hydroxphenylglycol measurement, urine	Acceptable (foundation metadata concept)
3-Methoxy-4-hydroxphenylglycol measurement, urine (procedure)	Preferred (foundation metadata concept)
3-Methoxy-4-hydroxymandelic acid measurement	Preferred (foundation metadata concept)
3-Methoxy-4-hydroxymandelic acid measurement (procedure)	Preferred (foundation metadata concept)
3-Methoxy-4-hydroxyphenylglycol measurement, urine	Acceptable (foundation metadata concept)
3-Methoxy-o-desmethylencainide measurement	Preferred (foundation metadata concept)
3-Methoxy-o-desmethylencainide measurement (procedure)	Preferred (foundation metadata concept)
3-Methyl,4-hydroxymandelate measurement	Preferred (foundation metadata concept)
3-Methyl,4-hydroxymandelate measurement (procedure)	Preferred (foundation metadata concept)
3-Methyl-1-pentyn-3-ol	Preferred (foundation metadata concept)
3-Methyl-1-pentyn-3-ol (substance)	Preferred (foundation metadata concept)
3-Methylcrotonyl glycine	Preferred (foundation metadata concept)
3-Methylcrotonyl glycine (substance)	Preferred (foundation metadata concept)
3-Methylcrotonyl-CoA carboxylase deficiency	Acceptable (foundation metadata concept)

Start Previous Page 100 of 12832 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001115012	United States of America English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001116013	US English	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001117016	United States of America English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)